| Translational activation of HIF1α by YB-1 promotes sarcoma metastasis AM El-Naggar, CJ Veinotte, H Cheng, TGP Grunewald, GL Negri, ... Cancer cell 27 (5), 682-697, 2015 | 292 | 2015 |
| Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy GM Tozer, SM Ameer-Beg, J Baker, PR Barber, SA Hill, RJ Hodgkiss, ... Advanced drug delivery reviews 57 (1), 135-152, 2005 | 206 | 2005 |
| Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenografts JHE Baker, KE Lindquist, LA Huxham, AH Kyle, JT Sy, AI Minchinton Clinical Cancer Research 14 (7), 2171-2179, 2008 | 132 | 2008 |
| Targeting hypoxia-induced carbonic anhydrase IX enhances immune-checkpoint blockade locally and systemically SC Chafe, PC McDonald, S Saberi, O Nemirovsky, G Venkateswaran, ... Cancer immunology research 7 (7), 1064-1078, 2019 | 111 | 2019 |
| Microregional effects of gemcitabine in HCT-116 xenografts LA Huxham, AH Kyle, JHE Baker, LK Nykilchuk, AI Minchinton Cancer research 64 (18), 6537-6541, 2004 | 96 | 2004 |
| Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma KKY Cham, JHE Baker, KS Takhar, JA Flexman, MQ Wong, DA Owen, ... British journal of cancer 103 (1), 52-60, 2010 | 87 | 2010 |
| Identification of breast cancer cell subtypes sensitive to ATG4B inhibition S Bortnik, C Choutka, HM Horlings, S Leung, JH Baker, C Lebovitz, ... Oncotarget 7 (41), 66970, 2016 | 73 | 2016 |
| Loss of the Notch effector RBPJ promotes tumorigenesis I Kulic, G Robertson, L Chang, JHE Baker, WW Lockwood, W Mok, ... Journal of Experimental Medicine 212 (1), 37-52, 2015 | 70 | 2015 |
| Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin JHE Baker, J Lam, AH Kyle, J Sy, T Oliver, SJ Co, WH Dragowska, ... Clinical Cancer Research 14 (22), 7260-7271, 2008 | 63 | 2008 |
| In vivo Evaluation of Mucoadhesive Nanoparticulate Docetaxel for Intravesical Treatment of Non–Muscle-Invasive Bladder Cancer C Mugabe, Y Matsui, AI So, ME Gleave, JHE Baker, AI Minchinton, ... Clinical Cancer Research 17 (9), 2788-2798, 2011 | 60 | 2011 |
| Hyperbranched polyglycerols as trimodal imaging agents: design, biocompatibility, and tumor uptake K Saatchi, P Soema, N Gelder, R Misri, K McPhee, JHE Baker, ... Bioconjugate chemistry 23 (3), 372-381, 2012 | 56 | 2012 |
| Targeting quiescent tumor cells via oxygen and IGF-I supplementation AH Kyle, JHE Baker, AI Minchinton Cancer research 72 (3), 801-809, 2012 | 46 | 2012 |
| Fungemia caused by an amphotericin B-resistant isolate of Sporothrix schenckii. Successful treatment with itraconazole. JH Baker, HC Goodpasture, HR Kuhns Jr, MG Rinaldi Archives of pathology & laboratory medicine 113 (11), 1279-1281, 1989 | 45 | 1989 |
| Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment JHE Baker, AH Kyle, SA Reinsberg, F Moosvi, HM Patrick, J Cran, ... Clinical & experimental metastasis 35, 691-705, 2018 | 43 | 2018 |
| Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanism A Patenaude, M Fuller, L Chang, F Wong, G Paliouras, R Shaw, AH Kyle, ... Cancer research 74 (9), 2402-2411, 2014 | 40 | 2014 |
| Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium C Mugabe, PA Raven, L Fazli, JHE Baker, JK Jackson, RT Liggins, AI So, ... Biomaterials 33 (2), 692-703, 2012 | 40 | 2012 |
| Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent AH Kyle, LA Huxham, JHE Baker, HE Burston, AI Minchinton Cancer research 63 (18), 5707-5711, 2003 | 38 | 2003 |
| Multiplex immunohistochemistry for mapping the tumor microenvironment J Kalra, J Baker Signal Transduction Immunohistochemistry: Methods and Protocols, 237-251, 2017 | 37 | 2017 |
| Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltration S Maltby, S Freeman, MJ Gold, JHE Baker, AI Minchinton, MR Gold, ... PLoS One 6 (4), e18160, 2011 | 35 | 2011 |
| The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity WH Dragowska, SA Weppler, MA Qadir, LY Wong, Y Franssen, ... BMC cancer 11 (1), 1-17, 2011 | 33 | 2011 |
